Yuntao Wu, Professor, Molecular and Microbiology, School of Systems Biology, is performing experiments to examine the antiviral activities of Respiratory Detox Shot (RDS).
RDS is a mixture of traditional Chinese medicine that has been used in China for the management of lung function and SARS-CoV and CoV-2 infection. Recent studies have shown that RDS has anti-coronavirus features that block the entry of both SARS-CoV and SARS-CoV-2 pseudo-virus into human cells.
Researchers in Wu's lab will also quantify the cytotoxicity of RDS in human cells.
Wu received $6,324 from Dejia Harmony for this project. This funding began in September 2020 and will end in late December 2020.
Study highlights how age affects nasal cell response to SARS-CoV-2